3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
8
Leukemia, Lymphocytic, Chronic, B-Cell
7
Lymphoma, Mantle-Cell
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Colorectal Neoplasms
5
Waldenstrom Macroglobulinemia
4
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Lymphoma, T-Cell, Cutaneous
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Extranodal NK-T-Cell
4
Leukemia, Prolymphocytic
4
Hodgkin Disease
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Burkitt Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sezary Syndrome
3
Neoplasms
3
Mycosis Fungoides
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Anaplastic
3
Leukemia, Myeloid, Acute
3
Immunoblastic Lymphadenopathy
3
Interventions
Pharmacogenomic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Adult Patients Who Are Receiving Oncologic Care
×
Pharmacogenomic Testing
×
Clear all
NCT06511401
2026-05-04
C-PAIN
University of Chicago
Phase NA
Recruiting
800 enrolled